Viewing Study NCT07047118


Ignite Creation Date: 2025-12-25 @ 4:46 AM
Ignite Modification Date: 2025-12-26 @ 3:47 AM
Study NCT ID: NCT07047118
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-05-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module